Our Future Outlook

This strategic alliance aims to advance the development of new cancer therapies based on Alluminox™ technology platform with institutions all over the world. Rakuten Medical and intuitions will collaborate to conduct studies based on the Alluminox™ technology platform and to determine study designs, combination therapies, and target patient populations for future clinical trials. In May 2020, Rakuten Medical, Inc. and MD Anderson bound the strategic alliance agreement.

We established a cancer research alliance network program, the Alluminox™ Alliance Institutes (IAI), in order to advance the development of new cancer therapies based on the Alluminox™ platform. Rakuten Medical will expand the IAI network to include premier cancer centers from around the world.

An institute as part of Alluminox™ Alliance Institutes (IAI) has discussions with other premier cancer centers from around the world. IAI designates a lead principal who will act as an Alluminox™ Advisor*.
*It depends on an institute to have an Alluminox™ Advisor.

• An Alluminox™ Advisor based on their expertise, actively participates in various research plans and Advisory board meetings.
• An Alluminox™ Advisor supports identification of additional investigators from the IAI.
• An Alluminox™ Advisor assists with education and training related to the use of Alluminox™ platform therapies.